Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teleflex Incorporated Common Stock (NY:TFX)

121.50 -1.42 (-1.16%)
Official Closing Price Updated: 7:00 PM EDT, Aug 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Teleflex Incorporated Common Stock

< Previous 1 2 3 4 5 6 7 Next >
TFX Q2 Deep Dive: Interventional Growth and Strategic Portfolio Shifts Define Outlook
Medical technology company Teleflex (NYSE:TFX) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 2.3% year on year to $780.9 million. Its non-GAAP profit of $3.73 per share was 10.8%... 
Via StockStory
Topics World Trade
Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know
A number of stocks jumped in the morning session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. The latest Consumer Price Index (CPI) report showed... 
Via StockStory
Topics Bonds Economy Stocks
3 Value Stocks with Questionable Fundamentals
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued... 
Via StockStory
Earnings Scheduled For July 31, 2025
 
Via Benzinga
How Is The Market Feeling About Teleflex?
 
Via Benzinga
Earnings Scheduled For May 1, 2025
 
Via Benzinga
Teleflex Inc (NYSE:TFX) Recognized as a Strong Value Investment with Solid Fundamentals
Teleflex Inc (NYSE:TFX) is a solid value stock with strong profitability, reasonable valuation, and stable financials, offering a potential safety net for investors. 
Via Chartmill
Deep Dive Into Teleflex Stock: Analyst Perspectives (7 Ratings)
 
Via Benzinga
Teleflex Inc (NYSE:TFX) Beats Q2 2025 Earnings Estimates with Strong Revenue and EPS Growth
Teleflex (NYSE:TFX) beats Q2 2025 estimates with $780.9M revenue and $3.73 EPS, driving a 15.9% pre-market surge. Strong growth in medical tech sector. 
Via Chartmill
Teleflex (NYSE:TFX) Beats Q2 Sales Targets
Medical technology company Teleflex (NYSE:TFX) announced better-than-expected revenue in Q2 CY2025, with sales up 2.3% year on year to $780.9 million. Its non-GAAP profit of $3.73 per share was 10.8%... 
Via StockStory
Teleflex (TFX) To Report Earnings Tomorrow: Here Is What To Expect
Medical technology company Teleflex (NYSE:TFX) will be reporting earnings this Thursday before market hours. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
1 Oversold Stock Set for a Comeback and 2 We Ignore
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
3 Small-Cap Stocks with Questionable Fundamentals
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Teleflex Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
 
Via Benzinga
TELEFLEX INC (NYSE:TFX) – A Potentially Undervalued Stock with Solid Fundamentals
TELEFLEX INC (NYSE:TFX) appears undervalued with strong profitability and financial health, making it a potential candidate for value investors. 
Via Chartmill
Masimo, STAAR Surgical, Teleflex, Omnicell, and Integra LifeSciences Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada. 
Via StockStory
Topics ETFs Stocks World Trade
3 Profitable Stocks Facing Headwinds
A company with profits isn’t always a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential. 
Via StockStory
3 Healthcare Stocks with Questionable Fundamentals
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Retirement Stocks
TFX Q1 Earnings Call: Guidance Cut and Strategic Shifts Dominate Amid Tariff Headwinds
Medical technology company Teleflex (NYSE:TFX) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 5% year on year to $700.7 million. Its non-GAAP profit of $2.91 per share was 0.9%... 
Via StockStory
Topics Economy World Trade
Q1 Earnings Highlights: Teleflex (NYSE:TFX) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Teleflex (NYSE:TFX) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy
Teleflex (NYSE:TFX) Reports Q1 In Line With Expectations
Medical technology company Teleflex (NYSE:TFX) met Wall Street’s revenue expectations in Q1 CY2025, but sales fell by 5% year on year to $700.7 million. Its non-GAAP profit of $2.91 per share was 0.9%... 
Via StockStory
What To Expect From Teleflex’s (TFX) Q1 Earnings
Medical technology company Teleflex (NYSE:TFX) will be reporting results tomorrow morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence World Trade
1 Cash-Producing Stock Worth Your Attention and 2 to Think Twice About
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Don't overlook TELEFLEX INC (NYSE:TFX)—it's a hidden gem with strong fundamentals and an attractive price tag.
TELEFLEX INC has a stellar value proposition. NYSE:TFX not only scores well in profitability, solvency, and liquidity but also maintains a very reasonable price point. 
Via Chartmill
Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at LeMaitre (NASDAQ:LMAT) and the best and... 
Via StockStory
Topics Artificial Intelligence Economy
Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - specialty stocks fared in... 
Via StockStory
Topics Artificial Intelligence Economy
3 of Wall Street’s Favorite Stocks with Mounting Challenges
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional... 
Via StockStory
3 Reasons TFX is Risky and 1 Stock to Buy Instead
Shareholders of Teleflex would probably like to forget the past six months even happened. The stock dropped 45.4% and now trades at $128.98. This was partly driven by its softer quarterly results and... 
Via StockStory
BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%,... 
Via StockStory
Topics Economy Government World Trade
Is the Market Bullish or Bearish on Teleflex?
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.